Affiliation: Sanford Burnham Prebys Medical Discovery Institute, NCI-designated Cancer Center

Dr. Yijuan Zhang is a Postdoctoral Associate in Dr. Cosimo Commisso's laboratory at Sanford Burnham Prebys Medical Discovery Institute’s NCI-designated Cancer Center. Her current research focuses on studying the mechanism and function of macropinocytosis in pancreatic cancer-associated fibroblasts. She received her PhD in Microbiology from the University of Wuhan and then worked as a research assistant on nanoscale material-based drug delivery for cancer chemotherapy and immunotherapy in Dr. Yifan Ma's group at Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences. Before her current position, she conducted her first postdoctoral studies in Dr. Xiaoting Zhang's laboratory at the University of Cincinnati, exploiting pRNA nanoparticle-delivered MED1 shRNAs to overcome tamoxifen resistance of breast cancer.